|
|
|
Constipation Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for
Constipation.
Please click "Search" to find Constipation clinical trials and medical research
studies or read below for information on Constipation diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 12 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Colonic Tube to Improve Bowel Function in Spinal Cord Injury - NCT00345397-53295
Conditions: Constipation - Fecal Incontinence - Spinal Cord Injury Location: Milwaukee, WI
- AcuGraph and Digestive Symptoms - NCT00846794-63017
Conditions: Digestive Disorders - Irritable Bowel Syndrome - Constipation - Diarrhea Location: Chesterfield, MO
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-33606
Conditions: Parkinson's Disease Location: Tampa, FL
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-77030
Conditions: Parkinson's Disease Location: Houston, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-06010
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Bristol, CT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-07712
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Ocean, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-07927
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cedar Knolls, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-08053
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Marlton, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-11501
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mineola, NY
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-14534
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pittsford, NY
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-15213
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pittsburgh, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-17604
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lancaster, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-18960
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sellersville, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-19056
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Levittown, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-19606
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lancaster, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-20636
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hollywood, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-20707
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Laurel, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-21215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Baltimore, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-21401
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Annapolis, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-23320
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chesapeake, VA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-24502
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lynchburg, VA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Winston Salem, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27203
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Asheboro, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27408
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Greensboro, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27599
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chapel Hill, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28075
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Harrisburg, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28078
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Huntersville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28211
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Charlotte, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28401
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Wilmington, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28546
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28562
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: New Bern, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28602
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hickory, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28625
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Statesville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Asheville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29414
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Charleston, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29485
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Summerville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29621
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anderson, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29681
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Simpsonville, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-30263
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Newnan, GA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32129
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Port Orange, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32205
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32256
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33021
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hollywood, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33156
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Miami, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33319
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lauderdale Lakes, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33426
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Boynton Beach, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33607
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tampa, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33782
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pinellas Park, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-34452
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Inverness, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-35209
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Birmingham, AL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-35801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Huntsville, AL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37203
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Nashville, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37421
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chattanooga, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37620
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Bristol, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37660
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Kingsport, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-38138
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Germantown, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-38801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tupelo, MS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-39202
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jackson, MS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-43560
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sylvania, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-43701
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Zanesville, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44060
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mentor, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44122
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Beachwood, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44281
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Wadsworth, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45224
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cincinnati, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45242
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cincinnati, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45440
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Dayton, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-46011
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anderson, IN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-48047
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chesterfield, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-48098
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Troy, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-49684
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Traverse City, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-50325
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Clive, IA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-52807
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Davenport, IA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-53215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Milwaukee, WI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-54601
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lacrosse, WI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-55446
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Plymouth, MN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-61602
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Peoria, IL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-65109
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jefferson City, MO
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66202
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mission, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Overland Park, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66606
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Topeka, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-70809
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Baton Rouge, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-71103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Shreveport, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-71201
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Monroe, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-72120
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sherwood, AR
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-73099
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Yukon, OK
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-73116
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Oklahoma City, OK
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-75061
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Irving, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-75605
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Longview, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77024
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Houston, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77479
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sugarland, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77701
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Beaumont, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-78229
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Antonio, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-79905
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: El Paso, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-80904
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Colorado Springs, CO
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-84107
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Salt Lake City, UT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-84405
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Ogden, UT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85020
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Phoenix, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85224
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chandler, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85710
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tuscon, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85715
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tucson, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-87108
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Albuquerque, NM
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-89104
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Henderson, NV
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-89128
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Las Vegas, NV
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-90045
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Los Angeles, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-91910
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chula Vista, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92024
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Encinitas, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92108
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92123
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92653
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Laguna Hills, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anaheim, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92840
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Garden Grove, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92868
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Orange, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-94070
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Carlos, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-95830
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sacramento, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-98664
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Vancouver, WA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-99208
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Spokane, WA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-02135
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Boston, MA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-06708
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Waterbury, CT
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-08360
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Vineland, NJ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-11021
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Great Neck, NY
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-11023
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Great Neck, NY
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-11214
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Brooklyn, NY
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-15206
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Pittsburgh, PA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-19020
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Bensalem, PA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-20815
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Chevy Chase, MD
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-21093
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Lutherville, MD
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-21742
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Hagerstown, MD
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-22911
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Charlottesville, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-23294
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Richmond, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-23502
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Norfolk, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-23507
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Norfolk, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-23606
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Newport News, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-24073
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Christianburg, VA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-27103
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Winston-Salem, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-27403
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Greensboro, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-27612
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Raleigh, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-28304
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Fayetteville, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-28401
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Wilmington, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-28601
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Hickory, NC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-29615
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Greenville, SC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-29651
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Greer, SC
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-30060
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Marietta, GA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-30067
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Marietta, GA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-30189
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Woodstock, GA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-30281
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Stockbridge, GA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-30342
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Atlanta, GA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-32405
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Panama City, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-32806
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Orlando, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33024
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Pembroke Pines, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33143
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Miami, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33458
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Jupiter, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33486
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Boca Raton, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33542
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Zephyrhills, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33606
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Tampa, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33709
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: St. Petersburg, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-33916
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Ft. Myers, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-34203
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Bradenton, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-34471
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Ocala, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-34601
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Brooksville, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-34655
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Trinity, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-34741
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Kissimmee, FL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-35205
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Birmingham, AL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-35215
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Birmingham, AL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-35801
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Huntsville, AL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-37205
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Nashville, TN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-40509
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Lexington, KY
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-42431
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Madisonville, KY
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-44122
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Cleveland, OH
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-44302
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Akron, OH
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-45219
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Cincinnati, OH
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-46237
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Indianapolis, IN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-46254
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Indianapolis, IN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-46514
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Elkhart, IN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-47714
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Evansville, IN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-52242
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Iowa City, IA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-53209
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Milwaukee, WI
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-55318
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Chaska, MN
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-58501
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Bismarck, ND
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-61107
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Rockford, IL
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-63110
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: St. Louis, MO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-63128
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: St. Louis, MO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-67005
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Arkansas City, KS
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-67114
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Newton, KS
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-67205
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Wichita, KS
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-67207
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Wichita, KS
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-73104
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Oklahoma City, OK
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-74135
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Tulsa, OK
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-75234
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Dallas, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-77090
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Houston, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-77566
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Lake Jackson, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-78209
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: San Antonio, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-78229
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: San Antonio, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-78705
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Austin, TX
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-80033
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Wheat Ridge, CO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-80205
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Denver, CO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-80304
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Boulder, CO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-80501
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Longmont, CO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-80909
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Colorado Springs, CO
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-83404
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Idaho Falls, ID
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-84102
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Salt Lake City, UT
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85012
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Phoenix, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85210
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Mesa, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85225
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Chandler, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85251
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Scottsdale, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85381
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Peoria, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-85741
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Tucson, AZ
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-87106
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Albuquerque, NM
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-90036
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Los Angeles, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-91361
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Westlake Village, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-91505
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Burbank, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-92024
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Encinitas, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-92610
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Foothill Ranch, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-92869
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Orange, CA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-98402
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Bellevue, WA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-98499
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Lakewood, WA
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00765999-98801
Conditions: Chronic Constipation - Irritable Bowel Syndrome With Constipation Location: Wenatchee, WA
- Cheno Effect on Transit in Health and IBS-C - NCT00912301-55905
Conditions: Constipation-Predominant Irritable Bowel Syndrome Location: Rochester, MN
- Colonic Transit Time Validation Study - NCT00857363-02114
Conditions: Constipation Location: Boston, MA
- Colonic Transit Time Validation Study - NCT00857363-14215
Conditions: Constipation Location: Buffalo, NY
- Colonic Transit Time Validation Study - NCT00857363-19140
Conditions: Constipation Location: Philadelphia, PA
- Colonic Transit Time Validation Study - NCT00857363-27157
Conditions: Constipation Location: Winston Salem, NC
- Colonic Transit Time Validation Study - NCT00857363-27516
Conditions: Constipation Location: Chapel Hill, NC
- Colonic Transit Time Validation Study - NCT00857363-48109
Conditions: Constipation Location: Ann Arbor, MI
- Colonic Transit Time Validation Study - NCT00857363-49007
Conditions: Constipation Location: Kalamazoo, MI
- Colonic Transit Time Validation Study - NCT00857363-52242
Conditions: Constipation Location: Iowa City, IA
- Colonic Transit Time Validation Study - NCT00857363-55905
Conditions: Constipation Location: Rochester, MN
- Colonic Transit Time Validation Study - NCT00857363-66160
Conditions: Constipation Location: Kansas City, KS
- Colonic Transit Time Validation Study - NCT00857363-85723
Conditions: Constipation Location: Tucson, AZ
- Colonic Transit Time Validation Study - NCT00857363-90048
Conditions: Constipation Location: Los Angeles, CA
- Comparison Trial of Enema vs. PEG 3350 for Constipation - NCT00467350-64108
Conditions: Constipation Location: Kansas City, MO
- Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling - NCT00677508-53226
Conditions: Constipation - Fecal Incontinence Location: Milwaukee, WI
- Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen - NCT01003249-27157
Conditions: Overactive Bladder - Constipation - Lower Urinary Tract Symptoms Location: Winston-Salem, NC
- Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit - NCT00844831-40202
Conditions: Constipation Location: Louisville, KY
- Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients - NCT00799201-25301
Conditions: Constipation - Analgesia Location: Charleston, WV
- Intestinal Microecology in Chronic Constipation - NCT00934479-85259
Conditions: Chronic Constipation - Irritable Bowel Syndrome Location: Scottsdale, AZ
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-Induced Constipation After Surgery in Inpatient Rehabilitation - NCT00662363-60302
Conditions: Constipation Location: Chicago, IL
- Lubiprostone as a Treatment for Constipation in Parkinson's Disease - NCT00669461-72205
Conditions: Constipation - Parkinson's Disease Location: Little Rock, AR
- Mechanism of Action of Biofeedback Therapy - NCT00988286-52242
Conditions: Constipation - Hyposensitivity - Hypersensitivity Location: Iowa City, IA
- Mechano-physiological Approach to Anorectal Function - NCT00219518-17033
Conditions: Constipation Location: Hershey, PA
- Methylnaltrexone for Opioid-induced Constipation in Cancer Patients - NCT01004393-05401
Conditions: Neoplasms - Constipation - Opioid-Related Disorders Location: Burlington, VT
- Randomized, Double-Blind, Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease - NCT00849784-33612
Conditions: Constipation - Parkinson's Disease Location: Tampa, FL
- Rectal Sensory Training - A Study of Two Techniques - NCT00982839-52242
Conditions: Rectal Hyposensitivity - Constipation Location: Iowa City, IA
- Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis - NCT00706004-72205
Conditions: Constipation - Cystic Fibrosis Location: Little Rock, AR
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects - NCT00858754-28731
Conditions: Opioid-induced Constipation Location: Flat Rock, NC
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects - NCT00858754-92637
Conditions: Opioid-induced Constipation Location: Laguna Hills, CA
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects - NCT00858754-93534
Conditions: Opioid-induced Constipation Location: Lancaster, CA
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects - NCT00858754-95476
Conditions: Opioid-induced Constipation Location: Sonoma, CA
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-10021
Conditions: Opioid-induced Constipation Location: New York, NY
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-10032
Conditions: Opioid-induced Constipation Location: New York, NY
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|